Log in

LON:GSK - GlaxoSmithKline Share Price, Forecast & News

GBX 1,562.20
-67.60 (-4.15 %)
(As of 02/28/2020 04:00 PM ET)
Today's Range
1,533.20
Now: GBX 1,562.20
1,602.40
50-Day Range
1,602.20
MA: GBX 1,747.56
1,846
52-Week Range
1,485.20
Now: GBX 1,562.20
1,857
Volume16.22 million shs
Average Volume9.12 million shs
Market Capitalization£78.37 billion
P/E Ratio16.87
Dividend Yield5.55%
BetaN/A
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-80475000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£33.75 billion
Cash FlowGBX 93.02 per share
Book ValueGBX 242 per share

Profitability

Miscellaneous

Employees95,490
Outstanding Shares5,016,410,112
Market Cap£78.37 billion
Next Earnings Date4/29/2020 (Estimated)
OptionableOptionable

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.


GlaxoSmithKline (LON:GSK) Frequently Asked Questions

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline announced a dividend on Wednesday, February 5th. Stockholders of record on Thursday, February 20th will be paid a dividend of GBX 23 per share on Thursday, April 9th. This represents a dividend yield of 1.32%. The ex-dividend date is Thursday, February 20th. This is a positive change from GlaxoSmithKline's previous dividend of $19.00. The official announcement can be accessed at this link. View GlaxoSmithKline's Dividend History.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (LON:GSK) issued its earnings results on Wednesday, April, 25th. The company reported $24.60 EPS for the quarter, topping analysts' consensus estimates of $24.30 by $0.30. View GlaxoSmithKline's Earnings History.

When is GlaxoSmithKline's next earnings date?

GlaxoSmithKline is scheduled to release their next quarterly earnings announcement on Wednesday, April 29th 2020. View Earnings Estimates for GlaxoSmithKline.

What price target have analysts set for GSK?

17 equities research analysts have issued 1-year target prices for GlaxoSmithKline's stock. Their forecasts range from GBX 1,550 to GBX 2,240. On average, they expect GlaxoSmithKline's share price to reach GBX 1,846.87 in the next year. This suggests a possible upside of 18.2% from the stock's current price. View Analyst Price Targets for GlaxoSmithKline.

What is the consensus analysts' recommendation for GlaxoSmithKline?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 3 sell ratings, 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for GlaxoSmithKline.

Has GlaxoSmithKline been receiving favorable news coverage?

Media coverage about GSK stock has trended extremely negative recently, InfoTrie reports. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. GlaxoSmithKline earned a daily sentiment score of -4.6 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for GlaxoSmithKline.

Who are some of GlaxoSmithKline's key competitors?

What other stocks do shareholders of GlaxoSmithKline own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AstraZeneca (AZN), General Electric (GE), Vodafone Group (VOD), Intel (INTC), Royal Dutch Shell (RDSB), Bank of America (BAC), AT&T (T), BP (BP), Allergan (AGN) and Pfizer (PFE).

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the folowing people:
  • Ms. Emma N. Walmsley, CEO & Director (Age 49)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 56)
  • Mr. Simon P. Dingemans, Exec. Director (Age 55)
  • Mr. Jack Bailey, Pres of US Pharmaceuticals
  • Mr. Iain James Mackay, CFO & Exec. Director (Age 57)

How do I buy shares of GlaxoSmithKline?

Shares of GSK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,562.20.

How big of a company is GlaxoSmithKline?

GlaxoSmithKline has a market capitalization of £78.37 billion and generates £33.75 billion in revenue each year. GlaxoSmithKline employs 95,490 workers across the globe.View Additional Information About GlaxoSmithKline.

What is GlaxoSmithKline's official website?

The official website for GlaxoSmithKline is http://www.gsk.com/.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000.


MarketBeat Community Rating for GlaxoSmithKline (LON GSK)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  961 (Vote Outperform)
Underperform Votes:  1,562 (Vote Underperform)
Total Votes:  2,523
MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Vote "Outperform" if you believe GSK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GSK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel